Bigelow Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,652
Closed -$318K 140
2020
Q4
$318K Sell
4,652
-650
-12% -$42.3K 0.17% 115
2020
Q3
$310K Sell
5,302
-766
-13% -$47.7K 0.18% 113
2020
Q2
$394K Sell
6,068
-1,941
-24% -$122K 0.26% 97
2020
Q1
$475K Sell
8,009
-321
-4% -$21.4K 0.36% 76
2019
Q4
$619K Buy
8,330
+11
+0.1% +$772 0.36% 77
2019
Q3
$525K Buy
8,319
+2,008
+32% +$119K 0.33% 88
2019
Q2
$344K Buy
6,311
+2,450
+63% +$132K 0.23% 113
2019
Q1
$208K Sell
3,861
-382
-9% -$23.6K 0.14% 147
2018
Q4
$278K Buy
4,243
+1,067
+34% +$79.6K 0.21% 124
2018
Q3
$250K Buy
+3,176
New +$227K 0.17% 132
2018
Q1
Sell
-3,570
Closed -$259K 149
2017
Q4
$259K Buy
+3,570
New +$260K 0.26% 90

Other funds holding CVS

Bigelow Investment Advisors's CVS Position: Q1 2021 in Review

Bigelow Investment Advisors sold out of CVS Health (CVS) in Q1 2021, closing a stake of 4,652 shares — an estimated $318K sold.

Bigelow Investment Advisors first reported a position in CVS in Q4 2017 and held it in 11 quarters. The position peaked at $619K in Q4 2019. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • Bigelow Investment Advisors reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
  • Bigelow Investment Advisors sold 4,652 CVS Health shares in Q1 2021, an estimated $318K.
  • Bigelow Investment Advisors first reported a position in CVS Health in Q4 2017 and held it in 11 quarters.
  • Bigelow Investment Advisors's CVS Health position peaked at $619K in Q4 2019.
  • 2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Bigelow Investment Advisors's 13F filing for Q1 2021, filed 6 May 2021.